ENSCW — Ensysce Biosciences Inc · rev $5.2M

Ensysce Biosciences Inc (ENSCW) common stock listed on US.

Latest reported ENSCW revenue for 2024-12-31 was $5.2M. Net income was -$8.0M. Revenue was up 133.6% from 2023-12-31 to 2024-12-31.

Use this ENSCW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ENSCW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ENSCW SEC filings page. Lician reads the product cache first so this HTML stays unique to Ensysce Biosciences Inc even when a live quote feed is slow.

Ensysce Biosciences Inc latest statements (FY2024)

Latest cached year on this hub. Full ENSCW income, balance, and cash tables.

  • Revenue$5.2M
  • Net Income-$8.0M
  • Total Assets$5.6M
  • Total Debt$0
  • Free Cash Flow$0

ENSCW recent filings